Xeno Transplants Corporation
XENO · OTC
3/31/2008 | 12/31/2007 | 9/30/2007 | 6/30/2007 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $110 | $170 | $141 | $87 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$220 | -$340 | -$282 | -$174 |
| Operating Expenses | -$110 | -$170 | -$141 | -$87 |
| Operating Income | $110 | $170 | $141 | $87 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$220 | -$340 | -$282 | -$174 |
| Pre-Tax Income | -$110 | -$170 | -$141 | -$87 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$110 | -$170 | -$141 | -$87 |
| % Margin | – | – | – | – |
| EPS | -0.003 | -0.004 | -0.004 | -0.002 |
| % Growth | 35.7% | -20% | -45.8% | – |
| EPS Diluted | -0.003 | -0.004 | -0.004 | -0.002 |
| Weighted Avg Shares Out | 40,364 | 40,364 | 40,325 | 36,754 |
| Weighted Avg Shares Out Dil | 40,364 | 40,364 | 40,325 | 36,754 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$110 | -$170 | -$141 | -$87 |
| % Margin | – | – | – | – |